SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Comment Letter for Charming Medical Ltd (MCTA) (CIK 0002035992) (MCTA) — May 19, 2025

Charming Medical Ltd (MCTA) (CIK 0002035992)
Date: May 19, 2025 · CIK: 0002035992 · Accession: 0000000000-25-005294

Financial Reporting Regulatory Compliance Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-287258

Date
May 19, 2025
Author
Kit Wong
Form
UPLOAD
Company
Charming Medical Ltd (MCTA) (CIK 0002035992)

Letter

May 19, 2025 Kit Wong Chief Executive Officer Charming Medical Limited Units 1803-1806, 18/F, Hang Lung Centre 2-20 Paterson Street, Causeway Bay, Hong Kong Re:Charming Medical Limited Registration Statement on Form F-1 Filed May 14, 2025 File No. 333-287258 Dear Kit Wong: We have reviewed your amended registration statement and have the following comment. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this letter, we may have additional comments. Unless we note otherwise, any references to prior comments are to comments in our March 25, 2025 letter. Form F-1 filed on May 14, 2025 Consolidated Financial Statements , page F-35 1.We note your registration statement includes audited financial statements that are older than 12 months. Since this represents an initial public offering of your ordinary shares, please update your financial statements pursuant to Item 8.A.4 of Form 20-F or provide the appropriate representations as to why such update is not necessary in an exhibit. Refer to Instruction 2 to Item 8.A.4. Please contact Christie Wong at 202-551-3684 or Terence O'Brien at 202-551-3355 if you have questions regarding comments on the financial statements and related matters. Please contact Lauren Hamill at 303-844-1008 or Chris Edwards at 202-551-6761 with any other questions.

May 19, 2025 Page 2 Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc:Jason Ye

Show Raw Text
May 19, 2025
Kit Wong
Chief Executive Officer
Charming Medical Limited
Units 1803-1806, 18/F, Hang Lung Centre
2-20 Paterson Street, Causeway Bay, Hong Kong
Re:Charming Medical Limited
Registration Statement on Form F-1
Filed May 14, 2025
File No. 333-287258
Dear Kit Wong:
            We have reviewed your amended registration statement and have the following
comment.
            Please respond to this letter by amending your registration statement and providing
the requested information. If you do not believe a comment applies to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
            After reviewing any amendment to your registration statement and the information
you provide in response to this letter, we may have additional comments. Unless we note
otherwise, any references to prior comments are to comments in our March 25, 2025 letter.
Form F-1 filed on May 14, 2025
Consolidated Financial Statements , page F-35
1.We note your registration statement includes audited financial statements that are
older than 12 months. Since this represents an initial public offering of your ordinary
shares, please update your financial statements pursuant to Item 8.A.4 of Form 20-F
or provide the appropriate representations as to why such update is not necessary in an
exhibit. Refer to Instruction 2 to Item 8.A.4.
            Please contact Christie Wong at 202-551-3684 or Terence O'Brien at 202-551-3355 if
you have questions regarding comments on the financial statements and related
matters. Please contact Lauren Hamill at 303-844-1008 or Chris Edwards at 202-551-6761
with any other questions.

May 19, 2025
Page 2
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:Jason Ye